← FDA ENFORCEMENT
D-0493-2025Class I

Umary-USA.com

What this record is not

A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.

Recalling firm
Umary-USA.com
Product type
Drug
Status
Completed
Report date
2025-06-25
Distribution
U.S. Nationwide via internet.
Firm state
AZ
Product quantity
1,704 30-count bottles
Initiated by
Voluntary: Firm initiated
Reason for recall

Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone and Diclofenac.

Product description

UMOVY ACIDO HIALURONICO, Conenido: 30 capletas de 850mg, distribuido por: EREN NATURAL S.A. DE C.V, Zappan, Jal. C.P, UPC 7503046054134

Code / lot info

All Lots; All Expiration Dates.

Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →